pain and infection. Moreover, significant volumetric resorption of the graft poses clinical problems in the case of block grafts from endochondral donor sites 1) . Therefore, there is a need for alternative biomaterials to autogenous bone.
The bone morphogenetic protein(BMP) is expected to be a good substitute for autogenous bone. BMP is the most promising osteoinductive protein for bone regeneration 2) . Since the discovery of BMPs 3) , more than 20 BMPs have been identified. Several, including BMP-2, -4, -6 and -7, have been reported to have significant osteoinductive potential 4, 5) . Among these, rhBMP-2 was found to have strong in vivo bone-inducing ability [5] [6] [7] . However, the application of BMPs alone is not enough to induce bone formation because the protein rapidly diffuses from the site of application.
Therefore, the use of a carrier system is essential for delivering and slowly releasingrhBMP-2 during the period of time required for bone formation 8, 9) .
For clinical success using rhBMPs, the carrier should be easy to manipulate and be made into a specific shape. It also needs to provide sufficient firmness against soft tissue pressure during the healing period.
Our previous studies searched for excellent rhBMP carriers, such as an absorbable collagen sponge(ACS) 9, 10) , ß-tricalcium phosphate(ß-TCP) 6, 9, 11) , a fibrin-fibronectin sealing system(FFSS) 12, 13) and a macroporous biphasic calcium phosphate (MBCP) block 14) . Each carrier material had its advantages and disadvantages. Although the ACS appeared to be an effective carrier in space-providing skeletal defects, it becomes victim to compressive forces when used for non-space-providing onlay indications.
Osteoconductive and porous ß-TCP provided sufficient firmness and good biocompatibility. However, it is not moldable and has limitations in providing space.
MBCP consists of an intimate mixture of hydroxyapatite(HA) and ß-TCP at varying HA/ß-TCP ratios 15) , and has been reported to have favorable osteoconductive properties [15] [16] [17] . MBCP has the required porous form, and can entrap rhBMP within its microporous structure so that the intrinsically diffusible rhBMP is retained prolonging its action. Moreover, the porous structure of MBCP allows the infiltration of cells. In addition, HA in MBCP provides sufficient mechanical strength to resist the compressive forces and maintains the volume of augmented bone. It was reported that a MBCP block might be a suitable carrier for rhBMP-2 to allow predictable bone formation in terms of the volumetric stability 14) .
The main requirement for successful bone regeneration is the stability of the graft material in the defect site as well as the prevention of soft connective tissue ingrowth into the defect area. The use of a barrier membrane to cover and retain the graft material might satisfy both prerequisites. The placement of a biocompatible ePTFE membrane or some other type of biodegradable barrier over bone defects might help guide bone regeneration 18) . However, there has been some controversy regarding the additional benefits of the membrane on bone regeneration by rhBMP [19] [20] [21] [22] [23] .
Therefore, this study examined the osteogenic effect of MBCP block combined with an ePTFE membrane as a carrier for recombinant human bone morphogenetic proteins (rhBMP-2) in a rat calvarial defect model.
The additive effect of ePTFE membrane on bone formation was also evaluated.
Materials and Methods

Animals
Twenty-eight male Sprague-Dawley rats (body weight, 200~300g) were used. They were maintained in plastic cages in a room with 12h-day/night cycles, an ambient temperature of 21ﾟC, and ad libitum access to water and a standard laboratory pellet diet. Animal selection and management, surgical protocol, and preparation followed the routines approved by the Institutional Animal Care and Use Committee, Yonsei
Medical Center, Seoul, Korea. , was created on the cranium using a saline-cooled trephine drill (3i, Palm Beach Gardens, FL, USA). The animals were divided into two groups containing 14 animals each and allowed to heal for 2 (7 rats) or 8 weeks (7 rats 
rhBMP-2 implant construction
Histologic and histomorphometric procedures
The animals were sacrificed by CO 2 analysis system. The following histomorphometric parameters were measured for each section (Fig. 2 ).
1) Augmented area (mm 2
) was measured as all tissues within the boundaries of the MBCP block, including new bone, the residual biomaterials, fatty marrow and fibrovascular tissue/marrow. 2) New bone area (mm 2 ) was determined by the newly formed bone area within the total augmented area.
3) Bone density (%) was determined by the percentage of newly formed bone area within the total augmented area: Bone density (%) = (New bone area / Augmented area) ×100
Statistical Analysis
Histomorphometric recordings from the samples were used to calculate group median and range. The
Wilcoxon two sample test was used for statistical analysis of the difference between two groups. P-value ＜0.05 was considered statistically significant.
Results
Clinical observation
Wound healing was generally uneventful and similar for all groups. There were no macroscopic signs of infection.
Histologic observation
At 2 weeks, new bone formation was observed in the bottom of the MBCP block (Fig. 3) . Bone formation was significantly enhanced at 8 weeks. The new bone appeared more lamellar at 8 weeks than that at 2 weeks. A large number of osteocytes, osteblasts, and osteoclasts were observed in the area of new bone formation. The incremental lines, fatty marrow and concentric ring of the Haversian system were also observed in this area. The pattern of newly formed bone moved from outside to the inside of the defect (Fig. 4 ).
There was no significantly different appearance by the membrane compared with rhBMP-2/MBCP block only. At 8 weeks, new bone formation was significant and more enhanced than at 2 weeks (Fig. 5, 6 ). In addition, an even bone formation pattern under membrane was observed (Fig. 6-B) . However, in the rhBMP-2/MBCP group, the bone formation pattern was irregular at the top of MBCP block (Fig. 4-B) .
The new bone formation pattern was similar in the central and base parts (bottom of defect) of the both groups (Fig. 4 -C, D and Fig. 6-C, D) . showed a slight beneficial effect on bone formation at 2 weeks, although this was not statistically significant as shown in Table 2 and Table 3 . Regarding the bone density, there were statistically significant differences between 2 weeks and 8 weeks results in both groups (P＜0.05). However, there were no significant differences between the two groups at 2 and 8 weeks of examination. In our previous study 24) , we demonstrated the bone regenerative effect of rhBMP-2 delivered with a MBCP block in a rat calvarial defect model. The rationale behind the study was to utilize the favorable bone healing capacity of the MBCP block, which has an osteoconductive effect, and the volumetric predictability over the healing time because of the low resorption rate and the resistance of the block type against soft tissue compression. The favorable osteoconductive effect of the MBCP in bone healing has been well documented [15] [16] [17] . It was suggested that the higher local In addition, the space should be maintained for a relatively long period in order to allow sufficient maturation of the newly formed bone. In terms of clinical bone tissue engineering, provision of the volume and shape of the bone tissue is a key factor for treatment success. In the previous study investigating the effect of rhBMP-2/MBCP block on bone formation in rat calvarial defects after 2 and 8 weeks healing period, ). Therefore, it was suggested that the MBCP block is an effective carrier system of rhBMP-2 with the volumetric stability 24) . Therefore, in this experiment, a MBCP block only group without rhBMP-2 was not included because the aim was to confirm the regenerative effects of the rhBMP-2/MBCP block and to determine whether or not the placement of an ePTFE barrier membrane would have a synergistic effect.
Histomorphometric analysis
In this study, there was significant better enhancement of bone formation in the defects of both the rhBMP-2/MBCP group and rhBMP-2/MBCP/ePTFE group at 8 weeks than at 2 weeks. However, although rhBMP-2/MBCP block induced new bone formation in the augmented defect, the placed ePTFE barrier membranes had no positive effect on bone regeneration.
There has been some controversy regarding the additional benefits of the membrane on bone regeneration by rhBMP [19] [20] [21] [22] [23] . An earlier study demonstrated that the initiation and rate of bone healing beneath the osteopromotive membranes can be enhanced significantly by the implantation of rhBMP-2.
However, membrane placement per se significantly hampered the osteoinductive capacity of the BMP 21) .
On the other hand, several studies 22, 23) . In our experiment, this effect of the MBCP block was confirmed by the fact that the ePTFE membrane generally showed a slight beneficial effect on bone formation at 2 weeks after rhBMP-2/MBCP block implantation than at 8 weeks, although this was not statistically significant ( Table 2 and Table 3 ). However, a synergistic effect of ePTFE might not be observed at 8 weeks because new bone was already induced by rhBMP-2 on the surface of the MBCP block in the initial healing stage, which might inhibit the in-growth of soft tissue into the defects ( Fig. 3 and Fig. 4 ).
The slight beneficial effect of the ePTFE membrane , the real importance of cell occlusion for optimal regeneration is unclear 30) . Recent studies have suggested that tissue occlusion does not appear to be a critical determinant for GTR but may be a requirement for optimal GTR 31, 32) . Therefore, as shown in our results, the tissue occlusion of the ePTFE membrane might have only an accessory effect when the space for bone regeneration is obtained using other materials, such as a MBCP block. However, if an absorbable and non-spacemaking material such as ACS is used as a rhBMP carrier, it would be advantageous to apply a membrane to obtain volume maintenance because barrier-membrane placement may be useful for graft retention as well as for predetermining the final shape of the regenerative site.
In conclusion, these results showed that the use of a rhBMP-2/MBCP block, regardless of combined use of an ePTFE membrane, can achieve bone augmentation with significant bone formation. This suggests that the MBCP block is a suitable carrier of rhBMP-2 and might be effective in maintaining the space needed for guided bone regeneration. In addition, these findings showed that the ePTFE membrane has no synergistic effect on bone formation when a MBCP block is used as a carrier for rhBMP-2.
